Evidence map›Paper›PMID 29388511›Full record

ArticlePrion2018

Impaired transport of intrinsically disordered proteins through the Sec61 and SecY translocon; implications for prion diseases.

Sebastian Jung, Jörg Tatzelt

Open access · goldAbstract read
In one paragraph

Article in Prion, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sebastian Junga Department Biochemistry of Neurodegenerative Diseases , Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum , Germany.ORCID 0000-0002-0365-5710
Jörg Tatzelta Department Biochemistry of Neurodegenerative Diseases , Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum , Germany.ORCID 0000-0001-5017-5528
Ruhr University Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prion protein (PrP) is composed of two major domains of similar size. The structured C-terminal domain contains three alpha-helical regions and a short two-stranded beta-sheet, while the N-terminal domain is intrinsically disordered. The analysis of PrP mutants with deletions in the C-terminal globular domain provided the first hint that intrinsically disordered domains are inefficiently transported into the endoplasmic reticulum through the Sec61 translocon. Interestingly, C-terminally truncated PrP mutants have been linked to inherited prion disease in humans and are characterized by inefficient ER import and the formation of neurotoxic PrP conformers. In a recent study we found that the Sec61 translocon in eukaryotic cells as well as the SecY translocon in bacteria is inherently deficient in translocating intrinsically disordered proteins. Moreover, our results suggest that translocon-associated components in eukaryotic cells enable the Sec61 complex to transport secretory proteins with extended unstructured domains such as PrP and shadoo.

Indexed as

AnimalsEndoplasmic ReticulumEscherichia coli ProteinsHumansIntrinsically Disordered ProteinsMiceMice, TransgenicPrion DiseasesPrion ProteinsPrionsProtein TransportSEC Translocation ChannelsEscherichia coli ProteinsIntrinsically Disordered ProteinsPrion ProteinsPrionsSEC Translocation ChannelsSecY protein, E coliER importintrinsically disorderedneurodegenerationprionSec61SecY

Identifiers

PMID29388511
PMCPMC6016518
OpenAlexW2792745973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.